###begin article-title 0
Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 904 914 904 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf, Mek1</italic>
###xml 919 923 919 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 546 551 <span type="species:ncbi:10090">mouse</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 979 984 <span type="species:ncbi:10090">mouse</span>
In the last years, RNA interference (RNAi)-mediated gene knockdown has developed into a routine method to assess gene function in cultured mammalian cells in a fast and easy manner. For the use of this technique in developing or adult mice, short hairpin (sh)RNA vectors expressed stably from the genome are a faster alternative to conventional knockout approaches. Here we describe an advanced strategy for conditional gene knockdown in mice, where we used the Cre/loxP system to activate RNAi in a time and tissue dependent manner in the adult mouse brain. By placing conditional RNAi constructs into the defined genomic Rosa26 locus and by using recombinase mediated cassette exchange (RMCE) instead of laborious homologous recombination, we developed a fast, easy and reproducible approach to assess gene function in adult mice. We applied this technique to three genes of the MAPK signaling pathway-Braf, Mek1 and Mek2-and demonstrate here the potential of this new tool in mouse mutagenesis.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 867 868 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1201 1202 1201 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 1509 1510 1509 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1511 1512 1511 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1939 1940 1939 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">Mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 1579 1583 <span type="species:ncbi:10090">mice</span>
###xml 1736 1741 <span type="species:ncbi:10090">mouse</span>
###xml 1933 1937 <span type="species:ncbi:10090">mice</span>
RNA interference (RNAi) has become an extremely useful genetic tool to study gene function in mammalian cells. The discovery that short double-stranded RNAs, known as short interfering (si)RNAs, avoid an interferon response and the global shutdown of translation has enabled the wide use of transient gene silencing in cultured cells and specific tissues of mice upon local administration (1). To elicit permanent gene silencing, short hairpin (sh)RNA expression vectors can be used. These vectors consist of an RNA polymerase III promoter producing short RNA fragments, which form hairpin structures. These shRNAs are processed by the RNAi machinery in the same way as linear double-stranded RNAs such that sequence-specific gene silencing occurs (2). Mice transgenic for shRNA vectors produce an all-over knockdown phenotype, similar to conventional knockout mice (3). To overcome the embryonic lethality of many mutants and to investigate gene functions in specific tissues or in a time dependent manner, conditional vectors have to be used. ShRNA expression can either be regulated by an inducing compound-like doxycycline acting on artificial regulatory sequences in the polymerase III promoter (4) or shRNA production is blocked by a transcriptional stop element that can be deleted through Cre mediated recombination. The latter Cre/loxP approach is similar to conditional knockout or knock in strategies where it is widely used. Various vector designs for Cre/loxP regulated RNAi have been described (5,6). Here, we show a fast and highly reproducible system to generate mice expressing shRNAs under the control of Cre recombinase. This tool can be applied to a great variety of biological questions since a large collection of mouse strains that express Cre recombinase in specific cell types is available and can be used to activate conditional shRNA vectors at different developmental stages and in selected cell types of mice (7).
###end p 4
###begin p 5
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 648 655 648 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 189 194 <span type="species:ncbi:4932">yeast</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 739 745 <span type="species:ncbi:10090">murine</span>
Mitogen activated protein kinases (MAPKs), also called extracellular signal-regulated kinases (ERKs), are a group of serine/threonine terminal protein kinases evolutionarily conserved from yeast to human. They form an intracellular signaling cascade regulating fundamental cellular functions including proliferation, cell survival and differentiation (8). The MAPK pathway plays also an important role in neurons as it is involved in synaptic plasticity, neuronal survival and regeneration (9). A regulatory function of MAPK signaling for anxiety and depression-like behavior of adult mice has been proposed (10) but not tested with genetic models in vivo. Here, we show that a conditional knockdown of Braf and Mek1 and Mek2 in the adult murine brain is possible with our RNAi approach, which gives the possibility to test the role of these genes in anxiety and depression-like behavior in vivo.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
LacZ and Luciferase shRNA vectors
###end title 7
###begin title 8
H1 promoter vectors
###end title 8
###begin p 9
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 449 455 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
The human H1 promoter was recovered as 119 bp SalI/KpnI fragment from the plasmid H1-RasGap (3) and ligated into the SalI/KpnI sites of pNEB193 (New England Biolabs). Plasmid H1-shLacZ coding for a lacZ specific shRNA was obtained by ligation of an oligonucleotide pair (5'-cccctggcgttacccaacttaatcgaagcttggattaagttgggtaacgccagggtttttggaaag-3', 5'-aattctttccaaaaaccctggcgttacccaacttaatccaagcttcgattaagttgggtaacgccagggggtac-3'; targeting nt 57-79 of E.coli lacZ gene) into the KpnI/EcoRI sites of pNEB-H1. pNEB-H1-shLacZ was opened with PsiI/KpnI and ligated with an oligonucleotide pair (5'-taacttcgtatagcatacattatacgaagttatggtac-3', 5'-cataacttcgtataatgtatgctatacgaagtta-3') to create H1-shLacZ-loxP1 or opened with KpnI and ligated with another oligonucleotide pair (5'-ataacttcgtatagcatacattatacgaagttatatatactagtcgacgtac-3', 5'-gtcgactagtatatataacttcgtataatgtatgctatacgaagttatgtac-3') to create H1-shLacZ-loxP3. To create H1-shLacZ-lox2, that contains a lox2272 sequence (11), pNEB-H1-shLacZ was opened with SalI/KpnI and ligated with a 120 bp DNA fragment from an oligonucleotide pair (5'-acgcgtcgacggatcgggagatccaatatttgcatgtcgctatgtgttctgggaaatcaccataaacgtgaaatata-3', 5'-ggggtaccgagtggtctcaataacttcgtataaggtatcctatacgaagttatatttcacgtttatggtgattt-3') that was annealed, extended with Klenow polymerase, and digested with SalI/KpnI. Upon removal of a 5' HindIII site from H1-shLacZ by SapI/PmeI digestion, end filling and religation, H1-shLacZ was opened within the shRNA loop region by HindIII and ligated with an oligonucleotide pair (5'-agctataacttcgtatagcatacattatacgaagttatggatcc-3', 5'-agctggatccataacttcgtataatgtatgctatacgaagttat-3') to create H1-shLacZ-loxP4 or with an other oligonucleotide pair (5'-agctataacttcgtatagcatacattatacgaagttat-3', 5'-agctataacttcgtataatgtatgctatacgaagttat-3') to obtain H1-shLacZ-loxP5.
###end p 9
###begin title 10
U6 promoter vectors
###end title 10
###begin p 11
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 325 332 325 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 325 332 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The pSHAG plasmid containing the human U6 promoter (12) was opened with BseRI/BamHI and ligated with a lacZ specific shRNA oligonucleotide pair (5'-gcgttacccaacttaatcgccttggaagcttgcaaggcgattaagttgggtaacgccttttttggaaa-3', 5'-gatctttccaaaaaaggcgttacccaacttaatcgccttgcaagcttccaaggcgattaagttgggtaacgccg-3'; targeting nt 61-85 of E. coli lacZ gene) to generate U6-shLacZ or ligated with a humanized F-Luciferase specific shRNA oligonucleotide pair (5'-tgcgctgctggtgccaacgaagcttggttggcaccagcagcgcacttttttggaaa-3', 5'-gatctttccaaaaaagtgcgctgctggtgccaaccaagcttcgttggcaccagcagcgcacg-3') to generate U6-shLuc. To create U6-shLacZ-loxP3, the U6-shLacZ segment was recloned into a modified pBluescript plasmid, opened with SgrAI at the transcriptional start site and ligated with an oligonucleotide pair (5'-ccggataacttcgtatagcatacattatacgaagttatatatactagtcgac-3', 5'-ccgggtcgactagtatatataacttcgtataatgtatgctatacgaagttat-3'). For U6-shLacZ-loxP4, U6-shLacZ was opened in the shRNA loop region with HindIII and ligated with a pair of oligonucleotides (5'-agctataacttcgtatagcatacattatacgaagttatggatcc-3', 5'-agctggatccataacttcgtataatgtatgctatacgaagttat-3') that introduce a loxP sequence and a 5' BamHI site. For U6-shLacZ-loxP5, U6-shLacZ was opened with HindIII and ligated with a pair of oligonucleotides (5'-agctataacttcgtatagcatacattatacgaagttat-3', 5'-agctataacttcgtataatgtatgctatacgaagttat-3') that inserts a loxP sequence into the shRNA loop in a symmetric fashion.
###end p 11
###begin p 12
###xml 942 976 942 976 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ataacttcgtatagcatacattatacgaagttat</underline>
###xml 1248 1282 1248 1282 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ataacttcgtatagcatacattatacgaagttat</underline>
To generate the conditional lacZ and Luciferase specific shRNA vectors U6-lox-lox-shluc and U6-lox-lox-shLacZ, plasmids U6-shLuc and U6-shLacZ were opened in the loop region with HindIII, the ends were filled with Klenow fragment and ligated with a 338 bp MlyI fragment serving as loxP flanked stop cassette. This MlyI fragment was cut from a pNEB193 based vector that contained a 19 bp R-Luciferase antisense and two polythymidine sequences, serving as termination signals, and that has been flanked with loxP sequences from oligonucleotide pairs that were ligated into the HindIII site (5'-agctgagtcgactgataacttcgtatagcatacattatacgaagttatggatcc-3', 5'-agctggatccataacttcgtataatgtatgctatacgaagttatcagtcgactc-3') and NdeI site (5'-tattttttggatccataacttcgtatagcatacattatacgaagttatgactggactc-3', 5'-tagagtccagtcataacttcgtataatgtatgctatacgaagttatggatccaaaaaa-3'). The sequence of the 338 bp stop cassette fragment is (loxP-sites underlined): 5'-ataacttcgtatagcatacattatacgaagttatggatccagcttggtagcgcggtgtattatactttttggaaagaattcactggccgtcgttttacaacgtcgtga ctgggaaaaccctggcgttacccaacttaatcgccttgcagcacatccccctttcgccagctggcgtaatagcgaagaggcccgcaccgatcgcccttcc caacagttgcgcagcctgaatggcgaatggcgcctgatgcggtattttctccttacgcatctgtgcggtatttcacaccgcatattttttggatccataacttcgtatagcatacattatacgaagttat-3'.
###end p 12
###begin p 13
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 241 248 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
To delete the loxP flanked stop cassette from U6-lox-lox-shluc and U6-lox-lox-shLacZ, the plasmids were transformed into Cre expressing bacteria (294cre; 13) and recombined subclones (U6-loxP5-shLuc, U6-loxP5-shLacZ) were retransformed into E. coli strain DH5alpha. All plasmids were grown in DH5alpha, isolated with Qiagen plasmid Maxiprep columns and the integrity of the promoter and shRNA regions was confirmed by DNA sequencing.
###end p 13
###begin title 14
Braf and Mek1/2 shRNA vectors
###end title 14
###begin p 15
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1/2</italic>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
The pSHAG plasmid containing the human U6 promoter (12) was opened with BseRI/BamHI and ligated with a Braf specific shRNA oligonucleotide pair (5'-gagaggagttacatgttgaagaagcttgttcaacatgtaactcctctccttttttggaaa-3', 5'-gatctttccaaaaaaggagaggagttacatgttgaacaagcttcttcaacatgtaactcctctccg-3', targeting 5'-ggagaggagttacatgttgaag-3' in Braf Exon 5) to generate pU6-shBraf or ligated with a Mek1/2 specific shRNA oligonucleotide pair (5'-acggcgagatcagcatctgcatgaagcttgatgcagatgctgatctcgccgtcttttttggaaa-3', 5'-gatctttccaaaaaagacggcgagatcagcatctgcatcaagcttcatgcagatgctgatctcgccgtcg-3', targeting 5'-gacggcgagatcagcatctgcatg-3' in Mek1 Exon 2 and Mek2 Exon 2) to generate pU6-shMek1/2. To create pU6-shBraf-flox and pU6-shMek1/2-flox, the vector pU6-shBraf or pU6-shMek1/2, respectively, was opened with HindIII in the loop region of the hairpin sequence, ends were filled with Klenow fragment, followed by ligation with the above described MlyI fragment containing the loxP-flanked stop cassette.
###end p 15
###begin title 16
Tissue culture
###end title 16
###begin p 17
###xml 232 233 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 427 436 424 433 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 526 529 523 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 908 910 902 904 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 1284 1286 1278 1280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 436 1915 433 1897 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="18">RNAi activity of H1 or U6 promoter based shRNA expression vectors modified by loxP sites. <bold>(A)</bold> Overview of the tested shRNA vectors. The position of the loxP sites (red triangle) in relation to the start of transcription (black arrow) and the shRNA region (blue arrows) are indicated. In the resulting shRNAs loxP derived sequences are shown in red color. All constructs contain identical sense and antisense shRNA sequences with specificity to &#946;-Galactosidase (lacZ). (<bold>B)</bold> Sequences of the H1 and U6 promoter constructs. The different positions of the loxP and lox2272 sites (red), respectively, within or outside of the promoter are shown. The nucleotide of the transcriptional start is highlighted in gray. In capital letters: TATA box of the promoter; bold: original loop region and in blue and underlined: shRNA sense and antisense regions. (<bold>C)</bold> Silencing activity of &#946;-Galactosidase specific shRNA vectors upon transient cotransfection with &#946;-Galactosidase and F-Luciferase expression plasmids into ES cells. Values are expressed as ratio of &#946;-Galactosidase to Luciferase activity in RLU in comparison to the positive control. The results obtained with the parental shRNA vectors H1-shLacZ and U6-shLacZ are shown as black columns. Numbers above the columns indicate the efficiency of silencing of &#946;-Galactosidase activity in percent in comparison to the positive control. All results from duplicate samples are expressed as mean values with standard deviation.</p>
###xml 436 1915 433 1897 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="18">RNAi activity of H1 or U6 promoter based shRNA expression vectors modified by loxP sites. <bold>(A)</bold> Overview of the tested shRNA vectors. The position of the loxP sites (red triangle) in relation to the start of transcription (black arrow) and the shRNA region (blue arrows) are indicated. In the resulting shRNAs loxP derived sequences are shown in red color. All constructs contain identical sense and antisense shRNA sequences with specificity to &#946;-Galactosidase (lacZ). (<bold>B)</bold> Sequences of the H1 and U6 promoter constructs. The different positions of the loxP and lox2272 sites (red), respectively, within or outside of the promoter are shown. The nucleotide of the transcriptional start is highlighted in gray. In capital letters: TATA box of the promoter; bold: original loop region and in blue and underlined: shRNA sense and antisense regions. (<bold>C)</bold> Silencing activity of &#946;-Galactosidase specific shRNA vectors upon transient cotransfection with &#946;-Galactosidase and F-Luciferase expression plasmids into ES cells. Values are expressed as ratio of &#946;-Galactosidase to Luciferase activity in RLU in comparison to the positive control. The results obtained with the parental shRNA vectors H1-shLacZ and U6-shLacZ are shown as black columns. Numbers above the columns indicate the efficiency of silencing of &#946;-Galactosidase activity in percent in comparison to the positive control. All results from duplicate samples are expressed as mean values with standard deviation.</p></caption>
###xml 1915 1915 1897 1897 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm475f1"/>
###xml 427 1915 424 1897 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="18">RNAi activity of H1 or U6 promoter based shRNA expression vectors modified by loxP sites. <bold>(A)</bold> Overview of the tested shRNA vectors. The position of the loxP sites (red triangle) in relation to the start of transcription (black arrow) and the shRNA region (blue arrows) are indicated. In the resulting shRNAs loxP derived sequences are shown in red color. All constructs contain identical sense and antisense shRNA sequences with specificity to &#946;-Galactosidase (lacZ). (<bold>B)</bold> Sequences of the H1 and U6 promoter constructs. The different positions of the loxP and lox2272 sites (red), respectively, within or outside of the promoter are shown. The nucleotide of the transcriptional start is highlighted in gray. In capital letters: TATA box of the promoter; bold: original loop region and in blue and underlined: shRNA sense and antisense regions. (<bold>C)</bold> Silencing activity of &#946;-Galactosidase specific shRNA vectors upon transient cotransfection with &#946;-Galactosidase and F-Luciferase expression plasmids into ES cells. Values are expressed as ratio of &#946;-Galactosidase to Luciferase activity in RLU in comparison to the positive control. The results obtained with the parental shRNA vectors H1-shLacZ and U6-shLacZ are shown as black columns. Numbers above the columns indicate the efficiency of silencing of &#946;-Galactosidase activity in percent in comparison to the positive control. All results from duplicate samples are expressed as mean values with standard deviation.</p></caption><graphic xlink:href="gkm475f1"/></fig>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 138 142 <span type="species:ncbi:9913">calf</span>
Mouse F1 ES cells (IDG3.2) were used for transient and stable transfections. Cells were grown in DMEM medium (Gibco) containing 15% fetal calf serum, 20 mM HEPES, 1x non-essential aminoacids, 0.1 mM beta-mercaptoethanol and 1.5 x 103 U/ml leukemia inhibiting factor on gelatin coated culture dishes for transient transfections or on mitomycin c treated embryonic fibroblasts for stable transfections and blastocyst injections. Figure 1.RNAi activity of H1 or U6 promoter based shRNA expression vectors modified by loxP sites. (A) Overview of the tested shRNA vectors. The position of the loxP sites (red triangle) in relation to the start of transcription (black arrow) and the shRNA region (blue arrows) are indicated. In the resulting shRNAs loxP derived sequences are shown in red color. All constructs contain identical sense and antisense shRNA sequences with specificity to beta-Galactosidase (lacZ). (B) Sequences of the H1 and U6 promoter constructs. The different positions of the loxP and lox2272 sites (red), respectively, within or outside of the promoter are shown. The nucleotide of the transcriptional start is highlighted in gray. In capital letters: TATA box of the promoter; bold: original loop region and in blue and underlined: shRNA sense and antisense regions. (C) Silencing activity of beta-Galactosidase specific shRNA vectors upon transient cotransfection with beta-Galactosidase and F-Luciferase expression plasmids into ES cells. Values are expressed as ratio of beta-Galactosidase to Luciferase activity in RLU in comparison to the positive control. The results obtained with the parental shRNA vectors H1-shLacZ and U6-shLacZ are shown as black columns. Numbers above the columns indicate the efficiency of silencing of beta-Galactosidase activity in percent in comparison to the positive control. All results from duplicate samples are expressed as mean values with standard deviation.
###end p 17
###begin p 18
###xml 90 93 90 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 472 474 469 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B)</bold>
###xml 848 850 845 847 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
RNAi activity of H1 or U6 promoter based shRNA expression vectors modified by loxP sites. (A) Overview of the tested shRNA vectors. The position of the loxP sites (red triangle) in relation to the start of transcription (black arrow) and the shRNA region (blue arrows) are indicated. In the resulting shRNAs loxP derived sequences are shown in red color. All constructs contain identical sense and antisense shRNA sequences with specificity to beta-Galactosidase (lacZ). (B) Sequences of the H1 and U6 promoter constructs. The different positions of the loxP and lox2272 sites (red), respectively, within or outside of the promoter are shown. The nucleotide of the transcriptional start is highlighted in gray. In capital letters: TATA box of the promoter; bold: original loop region and in blue and underlined: shRNA sense and antisense regions. (C) Silencing activity of beta-Galactosidase specific shRNA vectors upon transient cotransfection with beta-Galactosidase and F-Luciferase expression plasmids into ES cells. Values are expressed as ratio of beta-Galactosidase to Luciferase activity in RLU in comparison to the positive control. The results obtained with the parental shRNA vectors H1-shLacZ and U6-shLacZ are shown as black columns. Numbers above the columns indicate the efficiency of silencing of beta-Galactosidase activity in percent in comparison to the positive control. All results from duplicate samples are expressed as mean values with standard deviation.
###end p 18
###begin title 19
Transient transfections
###end title 19
###begin p 20
###xml 785 787 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 728 731 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Transient transfections with the lacZ and Luciferase specific shRNA vectors were performed with Fugene6 transfection reagent following the manufacturer's protocol (Roche Diagnostics). One day before transfection 60 000 ES cells were plated into each well of a 24 well culture plate. 150 ng of each supercoiled plasmid, a total amount of 450 ng, were complexed with 2 microl Fugene and transfected in duplicate into each well in 500 microl growth medium. For beta-Galactosidase and Luciferase measurements 150 ng of the beta-Galactosidase expression vector CMVbeta (Promega) were transfected together with 150 ng shRNA vector and 150 ng of the F-Luciferase expression vector pCMV-hLuc. pCMV-hLuc was generated by ligation of the CMV promoter (770 bp XhoI/EcoRI fragment) from pUHD17-1 (14) into the XhoI/HindIII sites of pGL3 basic (Promega) that contains a codon optimized F-Luciferase gene. The medium was changed after 24 h and the cells were lysed and chemiluminescence was detected 48 h after transfection.
###end p 20
###begin title 21
Chemiluminescence reporter gene assays
###end title 21
###begin p 22
###xml 441 442 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 444 445 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
The preparation of lysates and measurement of beta-Galactosidase activity were performed with the beta-Galactosidase analysis kit (Roche Diagnostics) following the manufacturer's protocol. Fifty microliter of freshly prepared lysates were measured for 5 s in an Orion I plate luminometer (Berthold). For the detection of F-Luciferase activity, 20 microl of each lysate were mixed with 100 mul Luciferase assay buffer (25 mM glycylglycine, KH2PO4, 4 mM EGTA, 2 mM ATP, 1 mM DTT, 100 microM Coenzyme A, 75 microM Luciferin, pH8) and measured for 5 s in the Orion I plate luminometer.
###end p 22
###begin p 23
For lacZ shRNA vectors, the relative light units (RLU) from beta-Galactosidase measurements were normalized to the Luciferase RLU of each sample, and for Luciferase shRNA vectors, RLU from beta-Galactosidase were used for normalization. The measurements of beta-Galactosidase RLU in Rosa26.5/26.9 ES cells were normalized to the total amount of protein in the lysates. Protein determinations were performed with the BCA protein assay kit (Pierce) following the manufacturer's instruction.
###end p 23
###begin title 24
Homologous recombination into Rosa26
###end title 24
###begin p 25
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 444 448 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 712 717 <span type="species:ncbi:10090">mouse</span>
The Rosa26 gene targeting vector pRosa26.5 was assembled from Rosa26-1 (15) by insertion of a splice acceptor element (16), the beta-Galactosidase (lacZ) coding region and polyA signal from CMVbeta (Promega), and the hygromycin resistance gene cassette from plasmid pgk-hygro-pA (a gift from P. Krimpenfort) into the XbaI site. The Rosa26 gene targeting vector pRosa26.9 was assembled from Rosa26-1 by insertion of a splice acceptor element, a SV40 late polyA signal, a neomycin resistance cassette from pgk-neo-pA (a gift from P. Soriano) and the conditional shRNA vector U6-lox-lox-shLacZ into the XbaI site; further details on cloning are available on request. The linearized vectors were electroporated into mouse F1-ES cells followed by selection with G418 (140 microg/ml) or hygromycin (125 U/ml) for 7 days. Resistant colonies were analyzed by Southern blotting of EcoRV digested genomic DNA using the Rosa26 5'-probe. One of the Rosa26.5 ES cell clones was further transfected with pRosa26.9 to introduce the conditional shRNA vector into the second Rosa26 locus.
###end p 25
###begin p 26
The Rosa26 5'-probe for Southern blotting is a 448 bp fragment of the Rosa26 locus 5' to the first exon, amplified with the following primer pair: 5'-aaggatactggggcatacg-3' and 5'-cttctcagctacctttacacacc-3'. With this probe, recombined Rosa26.5 ES cell clones were recognized by the presence of a 3.6 kb fragment in addition to the 11.5 kb Rosa26 wild type band after EcoRV digestion. Recombined Rosa26.9 ES cell clones were recognized by the presence of a 3.1 kb fragment in addition to the 3.6 kb Rosa26.5 band; a remaining 11.5 kb wild type band indicated a trisomy of chromosome 6 in these ES cells (data not shown).
###end p 26
###begin p 27
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
To activate the shRNA vector through Cre mediated recombination, double-targeted Rosa26.5/26.9 ES cells were transiently transfected with the Cre expression plasmid pCAG-cre-bpA. It was generated from pgk-cre-bpA (a gift from W. Muller) by EcoRI/PstI digestion to remove the pgk promoter and by insertion of the CAGGS promoter from CAGGS-FLPe (17) as a 1673 bp SalI/AlwNI fragment. Transfected subclones were expanded and analyzed by Southern blotting of BamHI digested genomic DNA for Cre mediated deletion of the stop cassette. The Rosa26 5'-probe detects a 6.5 kb band from the Rosa26.5 allele and a 5.8 kb band from the non-recombined Rosa26.9 allele, the same size is produced by the wild type locus. Cre mediated deletion can be recognized by the shift of the 5.8 kb Rosa26.9 band to a size of 9 kb since the deleted stop cassette contains a BamHI site (data not shown).
###end p 27
###begin p 28
Three non-recombined and two recombined subclones were further expanded without feeder cells on gelatin coated plates and analyzed for beta-Galactosidase activity by detection of chemiluminescence or by histochemical staining of fixed cells.
###end p 28
###begin title 29
beta-Galactosidase staining
###end title 29
###begin p 30
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 256 257 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were washed with phosphate buffered saline (PBS) and fixed for 5 min at room temperature in 4% paraformaldehyde in PBS. Next, the cells were washed twice with PBS and incubated in X-Gal staining solution (5 mM K3(Fe(CN)6), 5 mM K4(Fe(CN)6), 2 mM MgCl2, 1 mg/ml X-Gal (BioMol) in PBS) for 24 h at 37degreesC. Images were taken using an AxioCam HRc camera and the AxioVision program (Carl Zeiss).
###end p 30
###begin title 31
Cassette exchange vectors
###end title 31
###begin p 32
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 355 357 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
The cassette exchange acceptor vector pRosa26.10 was assembled from Rosa26-1 (15) by insertion of a splice acceptor sequence and a modified hygromycin resistance gene derived from pgk-hygro-pA (a gift from P. Krimpenfort) into the XbaI site. One 50 bp attP recognition site (5'-gtagtgccccaactggggtaacctttgagttctctcagttgggggcgtag-3') for phiC31 integrase (18) was placed between the pgk-promoter and the hygro-coding region. A second attP site was cloned in the same orientation downstream of the hygro-polyA region. Homologous recombination of pRosa26.10 in ES cells was achieved as reported above and hygromycin resistant colonies were analyzed for homologous recombination by Southern blotting of EcoRV digested genomic DNA using the Rosa26 5 '-probe (see above). Homologous recombination of the pRosa26.10 vector is indicated by a 4.5 kb band in addition to the 11.5 kb band from the wild type Rosa26 allele. The ES cell clone IDG26.10-3 was selected for further work, and the ability of these cells to colonize the germline in chimeric mice was confirmed (data not shown).
###end p 32
###begin p 33
The cassette exchange donor vector pRMCE was assembled within the backbone of pBluescript containing a modified polylinker region. One 53 bp attB recognition site (5'-ccgcggtgcgggtgccagggcgtgcccttgggctccccgggcgcgtactccac-3') of C31Int was cloned upstream of the neomycin coding and polyA region derived from pgk-neo-bpA, and a second attB site was cloned downstream in the same orientation. The multiple cloning site from pBluescript was inserted as a SacI/KpnI fragment between the polyA signal and the second attB site for subcloning of shRNA constructs.
###end p 33
###begin p 34
###xml 578 580 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 861 863 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 485 489 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 906 912 <span type="species:ncbi:9913">bovine</span>
The expression vector pCAG-C31Int was generated by PCR amplification of the 1900 bp coding region of phiC31 integrase from phage DNA (DSM-49156 received from DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany) with primers C31N (5'-taagtctagaccgatatgacacaaggggttgtgaccggggtg-3') and C31C (5'-cgactctagactaaaccttcctcttcttcttaggcgccgctacgtcttccgtgccgtcctgg-3'), digestion with XbaI and cloning into the XbaI site of pNEB193. Primer C31C introduces a SV40 derived nuclear localization signal to the C-terminus of phiC31 integrase as described (19). Upon sequence confirmation, the C31Int coding region was cloned as PacI-PstI fragment into pNEB-CAG downstream of the CAGGS promoter resulting in pCAG-C31Int(NLS). pNEB-CAG was generated by cloning the CAGGS promoter as 1673 bp blunt ended SalI/AlwNI fragment from pCAGGS-FLPe (17) into the filled BamHI site of pNEB193. A bovine polyA region from pgk-neo-bpA was added into the PmeI site of pCAG-C31Int(NLS) as 300 bp XbaI/NotI fragment resulting in pCAG-C31Int(NLS)-bpA. Further details on cloning strategies are available on request. The sequences and maps of pRosa26.10 and pCAG-C31(NLS)-bpA and a protocol for cassette exchange in ES cells are available at .
###end p 34
###begin title 35
Recombinase mediated cassette exchange
###end title 35
###begin p 36
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1/2</italic>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
Braf and Mek1/2 shRNA constructs were cloned as NotI/EcoRV fragment from pU6-shBraf-flox or pU6-shMek-flox, respectively, into pRMCE to generate the shRNA donor vector for RMCE. The donor vector was coelectroporated with a C31Int expression vector into mouse acceptor ES-cells (clone IDG26.10-3) followed by selection with G418 for 7 days. Resistant colonies were isolated and analyzed for cassette exchange by Southern blotting of ScaI digested genomic DNA using the Rosa26 5'-probe (see above). A 9.2 kb band in addition to the 6.1 kb band from the wild type Rosa26 locus indicated correct cassette exchange, whereas the original RMCE locus gives rise to a 7.6 kb band.
###end p 36
###begin title 37
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Generation of mutant mice, breeding and genotyping
###end title 37
###begin p 38
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 385 391 385 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 420 426 420 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
Positive ES cells containing the shBraf-flox or the shMek-flox construct, respectively, were injected into C57BL/6 blastocysts. Resulting chimeras were bred to C57BL/6 mice and offspring were tested for germline transmission. Heterozygous mice for the modified Rosa26 allele were crossed to CamKII-cre and Nestin-cre mice (on C57BL/6 background), respectively (20,21), to obtain shBraf+/flox/CamKII-cre mice and shMek1/2+/flox/Nestin-cre mice. Experiments on animals were carried out in accordance with national and institutional guidelines.
###end p 38
###begin p 39
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
Cre transgenes were genotyped by PCR using the primer pair 5'-ATGCCCAAGAAGAAGAGGAAGGT-3' and 5'-GAAATCAGTGCGTTCGAACGCTAGA-3' to amplify a 447 bp fragment from the Cre gene. The shBraf and shMek1/2 constructs in the Rosa26 locus were genotyped by Southern blotting of EcoRV digested genomic DNA using the Rosa26 5'-probe (see above). ShRNA-alleles are indicated by a 5.2 kb band in addition to the 11.5 kb band of the wildtype Rosa26 allele.
###end p 39
###begin title 40
Southern blotting
###end title 40
###begin p 41
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 318 320 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 333 335 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
DNA was extracted from brain tissue with the Wizard genomic DNA extraction kit (Promega). Ten micrograms of genomic DNA were digested with BamHI, run on a 0.8% agarose gel and blotted on a nylon membrane (Hybond N+, Amersham). Hybridization was performed overnight at 65degreesC with the Rosa26 5'-probe, labeled with 32P (5'-[alpha-32P]dCTP, Amersham). After washing, the membrane was exposed to a Kodak BioMax MS film.
###end p 41
###begin title 42
Northern blotting
###end title 42
###begin p 43
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 261 263 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 294 296 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 335 339 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 343 353 333 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-Actin</italic>
###xml 603 609 590 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 648 654 635 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1100 1101 1085 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1281 1283 1260 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1296 1298 1271 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Whole brains or half brains (with forebrain regions only, for Braf) were used for RNA extraction with TriReagent (Ambion). Northern blots for mRNA were performed with the NorthernMax-Gly system (Ambion). Membranes were hybridized overnight at 65degreesC with a 32P-labeled DNA probe (5'-[alpha-32P]dCTP, Amersham) against the 3'UTR of Mek1 or beta-Actin (Ambion). After washing, the membrane was exposed to a Kodak BioMax film. Quantification of band intensities was performed with an Imaging Plate and the FLA-8000 instrument (Fujifilm Life Science). For analysis of siRNAs, forebrain regions of shBraf+/flox/CamKII-cre and half brains of shMek1/2+/flox/Nestin-cre were used for extraction of small RNAs with the mirVana miRNA isolation kit (Ambion). Two or three micrograms of small RNA were separated on a Novex(R) TBE-urea gel (15%, Invitrogen). As positive control 0.05 pmol of an oligonucleotide corresponding to the antisense region of the hairpin was used (5'-ATGCAGATGCTGATCTCGCCGTC-3' for shMek1/2 and 5'-TTCAACATGTAACTCCTCTCC-3' for shBraf). RNA was blotted onto a nylon membrane (Hybond N+, Amersham), which was hybridized at 40degreesC with an oligonucleotide probe (5'-GACGGCGAGATCAGCATCTGCAT-3' for shMek1/2 and 5'-GGAGAGGAGTTACATGTTGAA-3' for shBraf), labeled with 32P (5'-[gamma-32P]dATP, Amersham). After washing, the membrane was exposed to a Kodak BioMax film.
###end p 43
###begin title 44
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
In situ hybridization
###end title 44
###begin p 45
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 825 832 799 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were asphyxiated with CO2 and perfused intracardially, after a brief rinse with ice-cold PBS, with ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.5). Brains were dissected and post-fixed for 2 h in 4% paraformaldehyde-PB. For embedding, the brains were dehydrated through an ascending ethanol scale (30%, 50%, 70%, 95%, 2x 100%, 1 h each passage), clarified in Rotihistol (Roth) 2x 45 min, equilibrated in 50% Rotihistol/50% paraffin for 1 h, and then transferred into paraffin at +65degreesC, 2x 1 h; they were equilibrated to room temperature in the last paraffin passage and kept at +4degreesC until cutting. Eight-micrometer sections were cut coronally and mounted on SuperFrost(R) Plus slides (Menzel-Glaeser); slides were dried overnight at 37degreesC and put at +4degreesC until proceeding with in situ hybridization (ISH).
###end p 45
###begin p 46
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 711 719 711 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 739 741 739 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 911 918 911 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1097 1098 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
For preparation of the Mek1 riboprobe, a DNA template was prepared by RT-PCR on total RNA extracted from adult brains of C57BL/6J mice. Total RNA was extracted using Trizol (Invitrogen) following manufacturer's instructions. Reverse transcription was performed using random hexamers and SuperScriptII (Invitrogen Kit) following manufacturer's instructions. PCR amplification was performed with the following oligonucleotides: 5'-GTCTGAGAGGGAGCCTTGTG-3' and 5'-GCCAGCATCTGAGCCTTTAG-3' (from NCBI acc #BC051137, nt 1303-2151). After linearization with the appropriate enzyme and purification (PCR purification Kit, QIAgen), two micrograms of DNA template were used for the synthesis of radiolabeled transcript by in vitro transcription with 35S-UTP (Amersham). After 20 min of DNase I (Roche) treatment, the probe was purified by the RNeasy Clean up protocol (QIAgen) and measured in a scintillation counter. For in situ hybridization, sections were dewaxed, pretreated and prehybridized as described previously (22). Subsequently, they were hybridized overnight with a probe concentration of 7 x 107 c.p.m./ml at 57degreesC and washed at 65degreesC in 0.1x SSC and 0.1 mM DTT. The hybridized slides were dipped in autoradiographic emulsion (Kodak, NTB2), developed after 3 weeks, counterstained with cresyl violet, dehydrated in an ascending ethanol scale and Xylol, and lidded with DPX. Images were taken using an AxioCam MRc camera and the AxioVision program (Carl Zeiss).
###end p 46
###begin p 47
Detailed protocols for the preparation of radiolabeled probes and ISH procedures are given at .
###end p 47
###begin title 48
Western blotting
###end title 48
###begin p 49
###xml 476 487 <span type="species:ncbi:3704">horseradish</span>
Total protein was extracted from brain tissue. Tissue was homogenized in RIPA buffer (50 mM Tris-HCl pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, protease inhibitor), sonificated and centrifuged. Fifty micrograms protein of each sample were run on a 10% Tris-HCl gel (Biorad) and blotted on a PVDF membrane (Pall). After blocking with 4% skim milk the membrane was incubated with the first antibody (1-3 h), washed with TBST, incubated with the second horseradish-peroxidase-conjugated antibody (1 h) and washed with TBST. The detection reaction was initiated with ECL detection reagents (Amersham) and the membrane was exposed to Hyperfilm (Amersham). For quantification of band intensities ECL plus was used instead of ECL detection reagent and chemifluorescent bands were detected with the FLA-8000 fluorescent image analyzer (Fujifilm Life Science). The antibodies used were anti-beta-ACTIN (AC-15, #ab6276, Abcam, 1 : 100 000, 1 h incubation), anti-MEK1 (sc-219, Santa Cruz Biotechnology, 1 : 1000, 1 h incubation), anti-MEK2 (# 610235, BD Transduction Laboratories, 1:2500, 1 h incubation) and anti-BRAF (sc-166, Santa Cruz Biotechnology, 1 : 600, 3 h incubation).
###end p 49
###begin title 50
RESULTS
###end title 50
###begin title 51
Development of conditional shRNA vectors
###end title 51
###begin p 52
###xml 561 569 561 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 840 848 840 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 982 990 982 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 536 541 <span type="species:ncbi:9606">human</span>
To control the activity of shRNA vectors through Cre/loxP mediated recombination, their transcription must be initially aborted by a loxP flanked stop element. The shRNA vector should be activated upon Cre mediated deletion of the stop segment. Since a single 34 bp loxP site remains in the activated vector after Cre recombination, we first tested whether this additional sequence disturbs RNAi efficiency. Therefore, we used vector configurations with different positions for the remaining loxP site, where the shRNA is driven by the human U6 or H1 promoter (Figure 1A and B). We found that the loxP site in all configurations of H1 promoter driven constructs strongly diminished the efficiency of gene silencing whereas the loxP site in all constructs driven by the U6 promoter did not significantly affect RNAi-mediated gene silencing (Figure 1C). Thus, the U6 but not the H1 promoter is of use for Cre mediated control of shRNA expression and we chose the loxP5 configuration (Figure 1A) as one effective configuration that includes the loxP sequence within the loop region.
###end p 52
###begin p 53
###xml 455 463 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 795 803 792 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1079 1087 1076 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1339 1347 1333 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1498 1507 1492 1501 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1555 1556 1549 1550 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1874 1875 1868 1869 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2275 2276 2263 2264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</italic>
###xml 2385 2386 2367 2368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</italic>
###xml 1507 2585 1501 2567 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">Cre/loxP controlled conditional shRNA vectors. (<bold>A</bold>) Scheme for the modification of an shRNA vector into a Cre/loxP controlled version by insertion of a loxP flanked stop cassette into the shRNA loop region. The conditional shRNA vector can be activated by excision of the stop cassette through Cre mediated deletion. A single loxP site remains within the shRNA loop. (<bold>B</bold>) Transient transfection of &#946;-Galactosidase (lacZ, blue columns) or F-Luciferase (Luc, orange columns) specific conditional shRNA vectors before (U6-lox-lox-shLuc; U6-lox-lox-shLacZ) and after excision of the loxP flanked stop cassette (U6-loxP5-shLuc; U6-loxP5-shLacZ) into ES cells. For F-Luciferase shRNA vectors values are expressed as ratio of Luciferase to &#946;-Galactosidase activity (left <italic>Y</italic> axis) and for &#946;-Galactosidase shRNA vectors as ratio of &#946;-Galactosidase to Luciferase activity (right <italic>Y</italic> axis), in comparison to the appropriate positive control. Results are expressed as mean values from duplicate samples with SD. U6-shLuc, U6-shLacZ: parental shRNA vectors; RLU: relative light units.</p>
###xml 1507 2585 1501 2567 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54">Cre/loxP controlled conditional shRNA vectors. (<bold>A</bold>) Scheme for the modification of an shRNA vector into a Cre/loxP controlled version by insertion of a loxP flanked stop cassette into the shRNA loop region. The conditional shRNA vector can be activated by excision of the stop cassette through Cre mediated deletion. A single loxP site remains within the shRNA loop. (<bold>B</bold>) Transient transfection of &#946;-Galactosidase (lacZ, blue columns) or F-Luciferase (Luc, orange columns) specific conditional shRNA vectors before (U6-lox-lox-shLuc; U6-lox-lox-shLacZ) and after excision of the loxP flanked stop cassette (U6-loxP5-shLuc; U6-loxP5-shLacZ) into ES cells. For F-Luciferase shRNA vectors values are expressed as ratio of Luciferase to &#946;-Galactosidase activity (left <italic>Y</italic> axis) and for &#946;-Galactosidase shRNA vectors as ratio of &#946;-Galactosidase to Luciferase activity (right <italic>Y</italic> axis), in comparison to the appropriate positive control. Results are expressed as mean values from duplicate samples with SD. U6-shLuc, U6-shLacZ: parental shRNA vectors; RLU: relative light units.</p></caption>
###xml 2585 2585 2567 2567 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm475f2"/>
###xml 1498 2585 1492 2567 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="54">Cre/loxP controlled conditional shRNA vectors. (<bold>A</bold>) Scheme for the modification of an shRNA vector into a Cre/loxP controlled version by insertion of a loxP flanked stop cassette into the shRNA loop region. The conditional shRNA vector can be activated by excision of the stop cassette through Cre mediated deletion. A single loxP site remains within the shRNA loop. (<bold>B</bold>) Transient transfection of &#946;-Galactosidase (lacZ, blue columns) or F-Luciferase (Luc, orange columns) specific conditional shRNA vectors before (U6-lox-lox-shLuc; U6-lox-lox-shLacZ) and after excision of the loxP flanked stop cassette (U6-loxP5-shLuc; U6-loxP5-shLacZ) into ES cells. For F-Luciferase shRNA vectors values are expressed as ratio of Luciferase to &#946;-Galactosidase activity (left <italic>Y</italic> axis) and for &#946;-Galactosidase shRNA vectors as ratio of &#946;-Galactosidase to Luciferase activity (right <italic>Y</italic> axis), in comparison to the appropriate positive control. Results are expressed as mean values from duplicate samples with SD. U6-shLuc, U6-shLacZ: parental shRNA vectors; RLU: relative light units.</p></caption><graphic xlink:href="gkm475f2"/></fig>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
According to this design we inserted a loxP-flanked 270 bp DNA segment, which includes termination sequences and serves as transcriptional stop element, in our parental U6 driven shRNA vector. The presence of the stop element in the 'off ' configuration of the conditional shRNA vector allows only the transcription of the sense region that does not induce RNA interference, provided that the shRNA construct follows the order 5'-sense-loop-antisense-3' (Figure 2A). Upon Cre mediated deletion of the stop cassette, the shRNA vector acquires the configuration of loxP5 with the remaining loxP site in the loop sequence. To assess the functionality of the stop element, it was first inserted into the loop region of U6-shRNA vectors against the beta-Galactosidase or F-Luciferase reporter genes (Figure 2A). Upon transient cotransfection with reporter gene expression plasmids into mouse ES cells, the efficiency of the stop cassette in the 'off ' state and RNAi efficiency in the 'on' state were analyzed and compared to the non-modified parental vectors U6-shLuc and U6-shLacZ (Figure 2B). The measurement of F-Luciferase and beta-Galactosidase activity from transfected cells showed that the 'off ' versions did not induce gene silencing whereas the 'on' versions induced the same level of RNAi as the parental, non-conditional vectors (Figure 2B). These results show that the stop element and our loxP5 configuration provide a way to control shRNA expression through Cre mediated recombination. Figure 2.Cre/loxP controlled conditional shRNA vectors. (A) Scheme for the modification of an shRNA vector into a Cre/loxP controlled version by insertion of a loxP flanked stop cassette into the shRNA loop region. The conditional shRNA vector can be activated by excision of the stop cassette through Cre mediated deletion. A single loxP site remains within the shRNA loop. (B) Transient transfection of beta-Galactosidase (lacZ, blue columns) or F-Luciferase (Luc, orange columns) specific conditional shRNA vectors before (U6-lox-lox-shLuc; U6-lox-lox-shLacZ) and after excision of the loxP flanked stop cassette (U6-loxP5-shLuc; U6-loxP5-shLacZ) into ES cells. For F-Luciferase shRNA vectors values are expressed as ratio of Luciferase to beta-Galactosidase activity (left Y axis) and for beta-Galactosidase shRNA vectors as ratio of beta-Galactosidase to Luciferase activity (right Y axis), in comparison to the appropriate positive control. Results are expressed as mean values from duplicate samples with SD. U6-shLuc, U6-shLacZ: parental shRNA vectors; RLU: relative light units.
###end p 53
###begin p 54
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 367 368 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 768 769 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</italic>
###xml 878 879 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</italic>
Cre/loxP controlled conditional shRNA vectors. (A) Scheme for the modification of an shRNA vector into a Cre/loxP controlled version by insertion of a loxP flanked stop cassette into the shRNA loop region. The conditional shRNA vector can be activated by excision of the stop cassette through Cre mediated deletion. A single loxP site remains within the shRNA loop. (B) Transient transfection of beta-Galactosidase (lacZ, blue columns) or F-Luciferase (Luc, orange columns) specific conditional shRNA vectors before (U6-lox-lox-shLuc; U6-lox-lox-shLacZ) and after excision of the loxP flanked stop cassette (U6-loxP5-shLuc; U6-loxP5-shLacZ) into ES cells. For F-Luciferase shRNA vectors values are expressed as ratio of Luciferase to beta-Galactosidase activity (left Y axis) and for beta-Galactosidase shRNA vectors as ratio of beta-Galactosidase to Luciferase activity (right Y axis), in comparison to the appropriate positive control. Results are expressed as mean values from duplicate samples with SD. U6-shLuc, U6-shLacZ: parental shRNA vectors; RLU: relative light units.
###end p 54
###begin title 55
Single copy shRNA expression from the Rosa26 locus
###end title 55
###begin p 56
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 960 968 951 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1399 1407 1376 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1528 1536 1498 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1756 1764 1726 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1768 1777 1738 1747 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 1888 1889 1858 1859 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2464 2465 2427 2428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2645 2647 2601 2603 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 1777 3060 1747 3002 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57">Cre mediated activation of a single copy conditional shRNA vector within the Rosa26 locus of murine ES cells. (<bold>A</bold>) One Rosa26 allele of ES cells was modified by a gene-targeting vector (R26.5) that introduced a splice acceptor-lacZ cassette and a hygromycin resistance gene such that &#946;-Galactosidase (lacZ) is expressed from the endogenous Rosa26 promoter. R26.5 ES cells were further modified with a gene targeting vector (R26.9) that introduced a neomycin resistance gene and the conditional shRNA vector U6-lox-lox-shLacZ. The R26.5/R26.9 ES cells were transiently transfected with a Cre expression vector and subclones that recombined the R26.9 allele (R26.9&#916;) were isolated. (<bold>B</bold>) X-Gal staining of fixed R26.5/R26.9 ES cells in comparison to a R26.5/R26.9&#916; clone shows highly reduced &#946;-Galactosidase activity in the latter cells (magnification 20&#215;). (<bold>C)</bold> Comparison of &#946;-Galactosidase activity in lysates of R26.5/R26.9 ES cells (mean of three non-deleted subclones, blue column) in comparison to two deleted subclones (R26.9&#916;-1, R26.9&#916;-2, red columns) and wild type ES cells (WT). Values are shown as &#946;-Galactosidase activity in RLU per micrograms protein of the lysates in comparison to the non-deleted clones and are expressed as mean values with SD.</p>
###xml 1777 3060 1747 3002 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57">Cre mediated activation of a single copy conditional shRNA vector within the Rosa26 locus of murine ES cells. (<bold>A</bold>) One Rosa26 allele of ES cells was modified by a gene-targeting vector (R26.5) that introduced a splice acceptor-lacZ cassette and a hygromycin resistance gene such that &#946;-Galactosidase (lacZ) is expressed from the endogenous Rosa26 promoter. R26.5 ES cells were further modified with a gene targeting vector (R26.9) that introduced a neomycin resistance gene and the conditional shRNA vector U6-lox-lox-shLacZ. The R26.5/R26.9 ES cells were transiently transfected with a Cre expression vector and subclones that recombined the R26.9 allele (R26.9&#916;) were isolated. (<bold>B</bold>) X-Gal staining of fixed R26.5/R26.9 ES cells in comparison to a R26.5/R26.9&#916; clone shows highly reduced &#946;-Galactosidase activity in the latter cells (magnification 20&#215;). (<bold>C)</bold> Comparison of &#946;-Galactosidase activity in lysates of R26.5/R26.9 ES cells (mean of three non-deleted subclones, blue column) in comparison to two deleted subclones (R26.9&#916;-1, R26.9&#916;-2, red columns) and wild type ES cells (WT). Values are shown as &#946;-Galactosidase activity in RLU per micrograms protein of the lysates in comparison to the non-deleted clones and are expressed as mean values with SD.</p></caption>
###xml 3060 3060 3002 3002 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm475f3"/>
###xml 1768 3060 1738 3002 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="57">Cre mediated activation of a single copy conditional shRNA vector within the Rosa26 locus of murine ES cells. (<bold>A</bold>) One Rosa26 allele of ES cells was modified by a gene-targeting vector (R26.5) that introduced a splice acceptor-lacZ cassette and a hygromycin resistance gene such that &#946;-Galactosidase (lacZ) is expressed from the endogenous Rosa26 promoter. R26.5 ES cells were further modified with a gene targeting vector (R26.9) that introduced a neomycin resistance gene and the conditional shRNA vector U6-lox-lox-shLacZ. The R26.5/R26.9 ES cells were transiently transfected with a Cre expression vector and subclones that recombined the R26.9 allele (R26.9&#916;) were isolated. (<bold>B</bold>) X-Gal staining of fixed R26.5/R26.9 ES cells in comparison to a R26.5/R26.9&#916; clone shows highly reduced &#946;-Galactosidase activity in the latter cells (magnification 20&#215;). (<bold>C)</bold> Comparison of &#946;-Galactosidase activity in lysates of R26.5/R26.9 ES cells (mean of three non-deleted subclones, blue column) in comparison to two deleted subclones (R26.9&#916;-1, R26.9&#916;-2, red columns) and wild type ES cells (WT). Values are shown as &#946;-Galactosidase activity in RLU per micrograms protein of the lysates in comparison to the non-deleted clones and are expressed as mean values with SD.</p></caption><graphic xlink:href="gkm475f3"/></fig>
###xml 303 309 <span type="species:ncbi:10090">murine</span>
###xml 518 524 <span type="species:ncbi:10090">murine</span>
###xml 1870 1876 <span type="species:ncbi:10090">murine</span>
For the genomic integration of conditional shRNA vectors, a single-copy approach is preferable since multi copy integrations could undergo unpredictable and non-functional rearrangements upon Cre mediated recombination. We tested the efficiency of a single shRNA vector copy in the Rosa26 locus (15) of murine ES cells with beta-Galactosidase as reporter gene. We first inserted a splice acceptor sequence and the beta-Galactosidase coding region by gene targeting downstream of the first exon of one Rosa26 allele of murine ES cells. These modified R26.5 ES cells express beta-Galactosidase from the endogenous, ubiquitously active Rosa26 promoter. Next, the second Rosa26 allele of R26.5 ES cells was targeted with a single copy of the conditional shRNA vector U6-lox-lox-shLacZ giving rise to R26.5/R26.9 ES cells. In the double-targeted R26.5/R26.9 cells, the shRNA vector stop cassette was deleted by transient transfection with a Cre expression plasmid (Figure 3A). Three ES cell clones harboring the non-activated and two clones carrying the recombined shRNA construct (R26.5/R26.9Delta cells) were isolated and analyzed for beta-Galactosidase activity by histochemical staining (X-Gal) and by a chemiluminescence assay using cell lysates. X-Gal staining revealed a strong reduction of beta-Galactosidase activity in R26.5/R26.9Delta ES cells as compared to non-recombined R26.5/R26.9 cells (Figure 3B). The quantitative analysis revealed that the beta-Galactosidase activity in R26.5/R26.9Delta cells is reduced by 90% (Figure 3C). Thus, a single genomic shRNA vector copy within the Rosa26 locus is sufficient to induce RNAi in ES cells and the extent of gene silencing can reach a similar level as obtained by transient transfections (compare to Figure 2B). Figure 3.Cre mediated activation of a single copy conditional shRNA vector within the Rosa26 locus of murine ES cells. (A) One Rosa26 allele of ES cells was modified by a gene-targeting vector (R26.5) that introduced a splice acceptor-lacZ cassette and a hygromycin resistance gene such that beta-Galactosidase (lacZ) is expressed from the endogenous Rosa26 promoter. R26.5 ES cells were further modified with a gene targeting vector (R26.9) that introduced a neomycin resistance gene and the conditional shRNA vector U6-lox-lox-shLacZ. The R26.5/R26.9 ES cells were transiently transfected with a Cre expression vector and subclones that recombined the R26.9 allele (R26.9Delta) were isolated. (B) X-Gal staining of fixed R26.5/R26.9 ES cells in comparison to a R26.5/R26.9Delta clone shows highly reduced beta-Galactosidase activity in the latter cells (magnification 20x). (C) Comparison of beta-Galactosidase activity in lysates of R26.5/R26.9 ES cells (mean of three non-deleted subclones, blue column) in comparison to two deleted subclones (R26.9Delta-1, R26.9Delta-2, red columns) and wild type ES cells (WT). Values are shown as beta-Galactosidase activity in RLU per micrograms protein of the lysates in comparison to the non-deleted clones and are expressed as mean values with SD.
###end p 56
###begin p 57
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 687 688 680 681 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 868 870 854 856 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 93 99 <span type="species:ncbi:10090">murine</span>
Cre mediated activation of a single copy conditional shRNA vector within the Rosa26 locus of murine ES cells. (A) One Rosa26 allele of ES cells was modified by a gene-targeting vector (R26.5) that introduced a splice acceptor-lacZ cassette and a hygromycin resistance gene such that beta-Galactosidase (lacZ) is expressed from the endogenous Rosa26 promoter. R26.5 ES cells were further modified with a gene targeting vector (R26.9) that introduced a neomycin resistance gene and the conditional shRNA vector U6-lox-lox-shLacZ. The R26.5/R26.9 ES cells were transiently transfected with a Cre expression vector and subclones that recombined the R26.9 allele (R26.9Delta) were isolated. (B) X-Gal staining of fixed R26.5/R26.9 ES cells in comparison to a R26.5/R26.9Delta clone shows highly reduced beta-Galactosidase activity in the latter cells (magnification 20x). (C) Comparison of beta-Galactosidase activity in lysates of R26.5/R26.9 ES cells (mean of three non-deleted subclones, blue column) in comparison to two deleted subclones (R26.9Delta-1, R26.9Delta-2, red columns) and wild type ES cells (WT). Values are shown as beta-Galactosidase activity in RLU per micrograms protein of the lysates in comparison to the non-deleted clones and are expressed as mean values with SD.
###end p 57
###begin p 58
###xml 497 505 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 723 731 721 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 976 984 974 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1120 1129 1118 1127 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1214 1215 1212 1213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1703 1704 1701 1702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1925 1926 1923 1924 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1129 2239 1127 2237 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">Vector construction and RMCE for the generation of shBraf-flox and shMek-flox mice. (<bold>A</bold>) The conditional shRNA expression cassette from the vector pbs-U6-shRNA-flox contains the U6 promoter in front of the sense (s) sequence of the shRNA, the loxP (lox) flanked stop cassette in the loop region and the antisense (as) shRNA sequence. The shRNA expression cassette is cloned into the RMCE donor vector pRMCE behind the promoterless neomycin selection marker (neo-bpA) so that the two attB sites from pRMCE flank the selection marker as well as the shRNA expression cassette. (<bold>B</bold>) Acceptor ES cells for RMCE harbor a Rosa26 allele where in intron 1&#8201;a splice acceptor (SA) is inserted followed by a pgk promoter (pgk) driving a hygromycin selection marker (hygro-bpA) which is flanked by attP sites. (<bold>C</bold>) Upon RMCE with C31Int, the attP flanked cassette in the acceptor ES cells from B is replaced by the attB flanked cassette from the donor vector in A. FRT (f) sites allow to excise the pgk promoter and the neomycin marker in recombined ES cells or mice. E: EcoRV; B: BamHI; probe: 5&#8242;-Rosa26 probe and E1: exon 1.</p>
###xml 1129 2239 1127 2237 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">Vector construction and RMCE for the generation of shBraf-flox and shMek-flox mice. (<bold>A</bold>) The conditional shRNA expression cassette from the vector pbs-U6-shRNA-flox contains the U6 promoter in front of the sense (s) sequence of the shRNA, the loxP (lox) flanked stop cassette in the loop region and the antisense (as) shRNA sequence. The shRNA expression cassette is cloned into the RMCE donor vector pRMCE behind the promoterless neomycin selection marker (neo-bpA) so that the two attB sites from pRMCE flank the selection marker as well as the shRNA expression cassette. (<bold>B</bold>) Acceptor ES cells for RMCE harbor a Rosa26 allele where in intron 1&#8201;a splice acceptor (SA) is inserted followed by a pgk promoter (pgk) driving a hygromycin selection marker (hygro-bpA) which is flanked by attP sites. (<bold>C</bold>) Upon RMCE with C31Int, the attP flanked cassette in the acceptor ES cells from B is replaced by the attB flanked cassette from the donor vector in A. FRT (f) sites allow to excise the pgk promoter and the neomycin marker in recombined ES cells or mice. E: EcoRV; B: BamHI; probe: 5&#8242;-Rosa26 probe and E1: exon 1.</p></caption>
###xml 2239 2239 2237 2237 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm475f4"/>
###xml 1120 2239 1118 2237 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="59">Vector construction and RMCE for the generation of shBraf-flox and shMek-flox mice. (<bold>A</bold>) The conditional shRNA expression cassette from the vector pbs-U6-shRNA-flox contains the U6 promoter in front of the sense (s) sequence of the shRNA, the loxP (lox) flanked stop cassette in the loop region and the antisense (as) shRNA sequence. The shRNA expression cassette is cloned into the RMCE donor vector pRMCE behind the promoterless neomycin selection marker (neo-bpA) so that the two attB sites from pRMCE flank the selection marker as well as the shRNA expression cassette. (<bold>B</bold>) Acceptor ES cells for RMCE harbor a Rosa26 allele where in intron 1&#8201;a splice acceptor (SA) is inserted followed by a pgk promoter (pgk) driving a hygromycin selection marker (hygro-bpA) which is flanked by attP sites. (<bold>C</bold>) Upon RMCE with C31Int, the attP flanked cassette in the acceptor ES cells from B is replaced by the attB flanked cassette from the donor vector in A. FRT (f) sites allow to excise the pgk promoter and the neomycin marker in recombined ES cells or mice. E: EcoRV; B: BamHI; probe: 5&#8242;-Rosa26 probe and E1: exon 1.</p></caption><graphic xlink:href="gkm475f4"/></fig>
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
###xml 2175 2179 <span type="species:ncbi:10090">mice</span>
To facilitate the insertion of shRNA vectors into the Rosa26 locus of ES cells for the fast generation of multiple knockdown mouse lines, we developed an approach for recombinase mediated cassette exchange (RMCE) using the integrase of phage phiC31 (C31Int). For this purpose, ES cells with a Rosa26 acceptor allele were generated. These cells harbor a pgk promoter driven hygromycin resistance gene, of which the coding and polyA region is flanked by attP recognition sites, in the Rosa26 locus (Figure 4B). The acceptor allele is designed such that the attP-flanked segment can be replaced by an attB-flanked construct from a donor plasmid (pRMCE) upon transfection of ES cells together with a C31Int expression plasmid (Figure 4A). The donor vector contains a promoterless neomycin resistance coding and polyA region and the shRNA expression cassette between the attB recognition sites. The shift from hygromycin to neomycin resistance in ES cells selects for RMCE events (Figure 4C), such that correct cassette exchange occurs at a frequency of 40-60% among the neomycin resistant ES cell colonies (data not shown). Figure 4.Vector construction and RMCE for the generation of shBraf-flox and shMek-flox mice. (A) The conditional shRNA expression cassette from the vector pbs-U6-shRNA-flox contains the U6 promoter in front of the sense (s) sequence of the shRNA, the loxP (lox) flanked stop cassette in the loop region and the antisense (as) shRNA sequence. The shRNA expression cassette is cloned into the RMCE donor vector pRMCE behind the promoterless neomycin selection marker (neo-bpA) so that the two attB sites from pRMCE flank the selection marker as well as the shRNA expression cassette. (B) Acceptor ES cells for RMCE harbor a Rosa26 allele where in intron 1 a splice acceptor (SA) is inserted followed by a pgk promoter (pgk) driving a hygromycin selection marker (hygro-bpA) which is flanked by attP sites. (C) Upon RMCE with C31Int, the attP flanked cassette in the acceptor ES cells from B is replaced by the attB flanked cassette from the donor vector in A. FRT (f) sites allow to excise the pgk promoter and the neomycin marker in recombined ES cells or mice. E: EcoRV; B: BamHI; probe: 5'-Rosa26 probe and E1: exon 1.
###end p 58
###begin p 59
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 574 575 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 796 797 796 797 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
Vector construction and RMCE for the generation of shBraf-flox and shMek-flox mice. (A) The conditional shRNA expression cassette from the vector pbs-U6-shRNA-flox contains the U6 promoter in front of the sense (s) sequence of the shRNA, the loxP (lox) flanked stop cassette in the loop region and the antisense (as) shRNA sequence. The shRNA expression cassette is cloned into the RMCE donor vector pRMCE behind the promoterless neomycin selection marker (neo-bpA) so that the two attB sites from pRMCE flank the selection marker as well as the shRNA expression cassette. (B) Acceptor ES cells for RMCE harbor a Rosa26 allele where in intron 1 a splice acceptor (SA) is inserted followed by a pgk promoter (pgk) driving a hygromycin selection marker (hygro-bpA) which is flanked by attP sites. (C) Upon RMCE with C31Int, the attP flanked cassette in the acceptor ES cells from B is replaced by the attB flanked cassette from the donor vector in A. FRT (f) sites allow to excise the pgk promoter and the neomycin marker in recombined ES cells or mice. E: EcoRV; B: BamHI; probe: 5'-Rosa26 probe and E1: exon 1.
###end p 59
###begin title 60
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1/2</italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Conditional Braf and Mek1/2 shRNA mice
###end title 60
###begin p 61
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 646 654 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
To study the effects of RNA interference against components of the MAPK cascade in vivo, we generated two conditional knockdown mouse lines. For the first mouse line, shBraf-flox, expressing an shRNA against Braf, we generated six shRNA vectors and tested their knockdown efficiency by transient transfection in cell culture (data not shown). In the vector containing the most efficient shRNA sequence, we inserted the stop cassette to block shRNA transcription before Cre recombination (pbs-U6-shBraf-flox). The shRNA expression cassette of this vector was in turn inserted into the donor vector pRMCE to generate recombinant ES cells via RMCE (Figure 4A).
###end p 61
###begin p 62
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
The second mouse line, shMek-flox, was generated in the same way as shBraf-flox. The shRNA sequence was chosen in a way that it targets Mek1 as well as Mek2, in a region where both mRNAs show 100% homology (in Exon 2 of both genes). Due to the restricted targeting region, here only two different shRNA vectors were generated and tested for efficiency.
###end p 62
###begin p 63
###xml 144 150 144 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">Mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Recombinant ES cells were injected into blastocysts to generate shBraf-flox and shMek-flox mice. Upon germline transmission, heterozygous shBraf+/flox mice were crossed to CamKII-cre mice to activate RNAi in forebrain neurons of adult mice (20). Mice carrying one modified Rosa26 allele with the shMek-flox construct were crossed to Nestin-cre mice, which express Cre recombinase in neuronal and glia cell precursors, to activate RNAi in the nervous system (21). All animals, containing the conditional shRNA construct or the activated shRNA together with the Cre transgene, were viable, fertile and showed no obvious phenotype.
###end p 63
###begin title 64
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Analysis of knockdown in shBraf-flox mice
###end title 64
###begin p 65
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 388 396 388 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 843 852 843 852 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 890 896 890 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 915 916 915 916 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1081 1087 1081 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1144 1150 1144 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1212 1218 1212 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1419 1420 1419 1420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1450 1454 1450 1454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 1587 1591 1587 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 1689 1691 1689 1691 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 1745 1751 1745 1751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 2192 2198 2189 2195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 2218 2224 2211 2217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 852 2236 852 2229 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="66">Analysis of RNA interference in shBraf<sup>+/flox</sup>/CamKII-cre mice. (<bold>A</bold>) Tissue-specific activation of shRNA in the brain with CamKII-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shBraf<sup>+/flox</sup>/CamKII-cre mice. Lane 1: DNA from whole brains of shBraf<sup>+/flox</sup> control mice; lane 2&#8211;10: DNA from indicated regions of shBraf<sup>+/flox</sup>/CamKII-cre mice. The wild type Rosa26 allele (wt) gives a 5.8&#8201;kb band and the band from the shRNA allele is shifted from 5.4&#8201;kb with the stop cassette (flox) to 8.6&#8201;kb after Cre recombination (del). (<bold>B</bold>) Expression of shRNA against <italic>Braf</italic> in adult forebrain. On a Northern blot with small RNAs against the sequence of shBraf the 21&#8201;nt band of the processed siRNA against <italic>Braf</italic> is only detectable with the control oligonucleotide and in mutant mice but not in control mice. (<bold>C)</bold> BRAF protein reduction in forebrain regions of shBraf<sup>+/flox</sup>/CamKII-cre mice. On a Western blot with protein from the indicated brain regions from adult mouse brain, knockdown of BRAF protein in forebrain regions of mutant mice is shown in comparison to the protein level from control mice. &#946;-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, +/flox: shBraf<sup>+/flox</sup> and +/&#916;: shBraf<sup>+/flox</sup>/CamKII-cre.</p>
###xml 852 2236 852 2229 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="66">Analysis of RNA interference in shBraf<sup>+/flox</sup>/CamKII-cre mice. (<bold>A</bold>) Tissue-specific activation of shRNA in the brain with CamKII-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shBraf<sup>+/flox</sup>/CamKII-cre mice. Lane 1: DNA from whole brains of shBraf<sup>+/flox</sup> control mice; lane 2&#8211;10: DNA from indicated regions of shBraf<sup>+/flox</sup>/CamKII-cre mice. The wild type Rosa26 allele (wt) gives a 5.8&#8201;kb band and the band from the shRNA allele is shifted from 5.4&#8201;kb with the stop cassette (flox) to 8.6&#8201;kb after Cre recombination (del). (<bold>B</bold>) Expression of shRNA against <italic>Braf</italic> in adult forebrain. On a Northern blot with small RNAs against the sequence of shBraf the 21&#8201;nt band of the processed siRNA against <italic>Braf</italic> is only detectable with the control oligonucleotide and in mutant mice but not in control mice. (<bold>C)</bold> BRAF protein reduction in forebrain regions of shBraf<sup>+/flox</sup>/CamKII-cre mice. On a Western blot with protein from the indicated brain regions from adult mouse brain, knockdown of BRAF protein in forebrain regions of mutant mice is shown in comparison to the protein level from control mice. &#946;-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, +/flox: shBraf<sup>+/flox</sup> and +/&#916;: shBraf<sup>+/flox</sup>/CamKII-cre.</p></caption>
###xml 2236 2236 2229 2229 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm475f5"/>
###xml 843 2236 843 2229 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="66">Analysis of RNA interference in shBraf<sup>+/flox</sup>/CamKII-cre mice. (<bold>A</bold>) Tissue-specific activation of shRNA in the brain with CamKII-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shBraf<sup>+/flox</sup>/CamKII-cre mice. Lane 1: DNA from whole brains of shBraf<sup>+/flox</sup> control mice; lane 2&#8211;10: DNA from indicated regions of shBraf<sup>+/flox</sup>/CamKII-cre mice. The wild type Rosa26 allele (wt) gives a 5.8&#8201;kb band and the band from the shRNA allele is shifted from 5.4&#8201;kb with the stop cassette (flox) to 8.6&#8201;kb after Cre recombination (del). (<bold>B</bold>) Expression of shRNA against <italic>Braf</italic> in adult forebrain. On a Northern blot with small RNAs against the sequence of shBraf the 21&#8201;nt band of the processed siRNA against <italic>Braf</italic> is only detectable with the control oligonucleotide and in mutant mice but not in control mice. (<bold>C)</bold> BRAF protein reduction in forebrain regions of shBraf<sup>+/flox</sup>/CamKII-cre mice. On a Western blot with protein from the indicated brain regions from adult mouse brain, knockdown of BRAF protein in forebrain regions of mutant mice is shown in comparison to the protein level from control mice. &#946;-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, +/flox: shBraf<sup>+/flox</sup> and +/&#916;: shBraf<sup>+/flox</sup>/CamKII-cre.</p></caption><graphic xlink:href="gkm475f5"/></fig>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 1099 1103 <span type="species:ncbi:10090">mice</span>
###xml 1159 1163 <span type="species:ncbi:10090">mice</span>
###xml 1230 1234 <span type="species:ncbi:10090">mice</span>
###xml 1658 1662 <span type="species:ncbi:10090">mice</span>
###xml 1682 1686 <span type="species:ncbi:10090">mice</span>
###xml 1763 1767 <span type="species:ncbi:10090">mice</span>
###xml 1844 1849 <span type="species:ncbi:10090">mouse</span>
###xml 1914 1918 <span type="species:ncbi:10090">mice</span>
###xml 1976 1980 <span type="species:ncbi:10090">mice</span>
Cre recombinase under the CamKII promoter activates the shRNA only in neurons of the adult forebrain (20). To show the deletion of the stop cassette in the U6-shBraf-flox element, a Southern blot analysis with genomic DNA from different brain regions was performed. A shift of the 5.4 kb band with the stop cassette to an 8.6 kb band after Cre recombination indicates activation of RNAi (Figure 5A). This larger band is visible only in forebrain regions of mutant mice, like the olfactory bulb, the hippocampus, striatum, cortex and very weak in the thalamus, but not in more posterior parts of the brain of these mice or in control mice. As expected, the 5.4 kb band from the inactive shRNA allele is still visible in all the forebrain regions of mutant mice, resulting from non-neuronal cells in the forebrain expressing no Cre recombinase. Figure 5.Analysis of RNA interference in shBraf+/flox/CamKII-cre mice. (A) Tissue-specific activation of shRNA in the brain with CamKII-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shBraf+/flox/CamKII-cre mice. Lane 1: DNA from whole brains of shBraf+/flox control mice; lane 2-10: DNA from indicated regions of shBraf+/flox/CamKII-cre mice. The wild type Rosa26 allele (wt) gives a 5.8 kb band and the band from the shRNA allele is shifted from 5.4 kb with the stop cassette (flox) to 8.6 kb after Cre recombination (del). (B) Expression of shRNA against Braf in adult forebrain. On a Northern blot with small RNAs against the sequence of shBraf the 21 nt band of the processed siRNA against Braf is only detectable with the control oligonucleotide and in mutant mice but not in control mice. (C) BRAF protein reduction in forebrain regions of shBraf+/flox/CamKII-cre mice. On a Western blot with protein from the indicated brain regions from adult mouse brain, knockdown of BRAF protein in forebrain regions of mutant mice is shown in comparison to the protein level from control mice. beta-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, +/flox: shBraf+/flox and +/Delta: shBraf+/flox/CamKII-cre.
###end p 65
###begin p 66
###xml 38 44 38 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 63 64 63 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 229 235 229 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 292 298 292 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 360 366 360 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 567 568 567 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 735 739 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 837 839 837 839 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C)</bold>
###xml 893 899 893 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1340 1346 1337 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1366 1372 1359 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 992 997 <span type="species:ncbi:10090">mouse</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
Analysis of RNA interference in shBraf+/flox/CamKII-cre mice. (A) Tissue-specific activation of shRNA in the brain with CamKII-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shBraf+/flox/CamKII-cre mice. Lane 1: DNA from whole brains of shBraf+/flox control mice; lane 2-10: DNA from indicated regions of shBraf+/flox/CamKII-cre mice. The wild type Rosa26 allele (wt) gives a 5.8 kb band and the band from the shRNA allele is shifted from 5.4 kb with the stop cassette (flox) to 8.6 kb after Cre recombination (del). (B) Expression of shRNA against Braf in adult forebrain. On a Northern blot with small RNAs against the sequence of shBraf the 21 nt band of the processed siRNA against Braf is only detectable with the control oligonucleotide and in mutant mice but not in control mice. (C) BRAF protein reduction in forebrain regions of shBraf+/flox/CamKII-cre mice. On a Western blot with protein from the indicated brain regions from adult mouse brain, knockdown of BRAF protein in forebrain regions of mutant mice is shown in comparison to the protein level from control mice. beta-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, +/flox: shBraf+/flox and +/Delta: shBraf+/flox/CamKII-cre.
###end p 66
###begin p 67
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 568 576 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
Consistent with the situation on the genomic level, we could show expression of the Braf shRNA in mutant mice, but not in control mice without Cre transgene, on a Northern blot with short RNAs (Figure 5B). At the protein level, reduction of BRAF protein is visible in brain regions of mutant mice where Cre recombination occurred (Figure 5C). Slight protein knockdown of BRAF in midbrain and cerebellum, where no Cre recombination on the DNA level is visible, may be due to recombination in a small fraction of cells that remains undetected by Southern blot analysis (Figure 5A). Since the BRAF expression in these regions is low and restricted (23), the limited Cre activity could still result in visible protein knockdown if a substantial fraction of Braf expressing neurons also coexpress Cre recombinase. No protein knockdown is visible in the brainstem. Estimation of levels of protein reduction in forebrain regions revealed a knockdown of approximately70% compared to protein expression in control mice.
###end p 67
###begin title 68
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Analysis of knockdown in shMek-flox mice
###end title 68
###begin p 69
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 428 436 428 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 883 891 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 895 904 895 904 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 941 947 941 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 966 967 966 967 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1131 1137 1131 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1193 1199 1193 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1260 1266 1260 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1467 1468 1467 1468 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1498 1502 1498 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1507 1511 1507 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 1645 1649 1645 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1654 1658 1654 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 1758 1761 1758 1761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;E</bold>
###xml 1776 1780 1776 1780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1843 1844 1843 1844 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1846 1850 1846 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1929 1939 1917 1924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-Actin</italic>
###xml 1971 1978 1956 1963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 2001 2005 1986 1990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 2151 2155 2136 2140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 2178 2179 2163 2164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2183 2184 2168 2169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 2239 2245 2224 2230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 2675 2681 2657 2663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 2697 2703 2675 2681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 904 2743 904 2721 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="70">Analysis of RNA interference in shMek<sup>+/flox</sup>/Nestin-cre mice. (<bold>A</bold>) Tissue specific activation of shRNA in the brain with Nestin-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shMek<sup>+/flox</sup>/Nestin-cre mice. Lane 1: DNA from whole brains of shMek<sup>+/flox</sup> control mice; lane 2&#8211;10: DNA from indicated regions of shMek<sup>+/flox</sup>/Nestin-cre mice. The wild type Rosa26 allele (wt) gives a 5.8&#8201;kb band and the band from the shRNA allele is shifted from 5.4&#8201;kb with the stop cassette (flox) to 8.6&#8201;kb after Cre recombination (del). (<bold>B</bold>) Expression of shRNA against <italic>Mek1</italic> and <italic>Mek2</italic> in whole adult brain. On a Northern blot with small RNAs against the sequence of shMek the 23&#8201;nt band of the processed siRNA against <italic>Mek1</italic> and <italic>Mek2</italic> is highly detectable with the control oligonucleotide and in mutant mice but not in control mice. (<bold>C&#8211;E</bold>) Knockdown of <italic>Mek1</italic> mRNA. On a Northern blot of total RNA from whole adult brain (<bold>C</bold>) <italic>Mek1</italic> mRNA from mutant mice is decreased &#8764;65% compared to control mice. <italic>&#946;-Actin</italic> was used as a loading control. <italic>In situ</italic> hybridization against <italic>Mek1</italic> mRNA on coronal brain sections shows the knockdown effect throughout the brain of mutant mice (E) in contrast to the high wildtype expression of <italic>Mek1</italic> mRNA in control mice (<bold>D</bold>). (<bold>F</bold>) MEK1 and MEK2 protein reduction in the brain of shMek<sup>+/flox</sup>/Nestin-cre mice. On a Western blot with protein from the indicated regions from adult brain, knockdown of MEK1 and MEK2 in mutant mice is shown in comparison to control mice. &#946;-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, Cx: cortex, Amy: amygdala, Hy: hypothalamus, +/flox: shMek<sup>+/flox</sup>, +/&#916;: shMek<sup>+/flox</sup>/Nestin-cre; scale bar in D and E: 1&#8201;mm.</p>
###xml 904 2743 904 2721 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="70">Analysis of RNA interference in shMek<sup>+/flox</sup>/Nestin-cre mice. (<bold>A</bold>) Tissue specific activation of shRNA in the brain with Nestin-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shMek<sup>+/flox</sup>/Nestin-cre mice. Lane 1: DNA from whole brains of shMek<sup>+/flox</sup> control mice; lane 2&#8211;10: DNA from indicated regions of shMek<sup>+/flox</sup>/Nestin-cre mice. The wild type Rosa26 allele (wt) gives a 5.8&#8201;kb band and the band from the shRNA allele is shifted from 5.4&#8201;kb with the stop cassette (flox) to 8.6&#8201;kb after Cre recombination (del). (<bold>B</bold>) Expression of shRNA against <italic>Mek1</italic> and <italic>Mek2</italic> in whole adult brain. On a Northern blot with small RNAs against the sequence of shMek the 23&#8201;nt band of the processed siRNA against <italic>Mek1</italic> and <italic>Mek2</italic> is highly detectable with the control oligonucleotide and in mutant mice but not in control mice. (<bold>C&#8211;E</bold>) Knockdown of <italic>Mek1</italic> mRNA. On a Northern blot of total RNA from whole adult brain (<bold>C</bold>) <italic>Mek1</italic> mRNA from mutant mice is decreased &#8764;65% compared to control mice. <italic>&#946;-Actin</italic> was used as a loading control. <italic>In situ</italic> hybridization against <italic>Mek1</italic> mRNA on coronal brain sections shows the knockdown effect throughout the brain of mutant mice (E) in contrast to the high wildtype expression of <italic>Mek1</italic> mRNA in control mice (<bold>D</bold>). (<bold>F</bold>) MEK1 and MEK2 protein reduction in the brain of shMek<sup>+/flox</sup>/Nestin-cre mice. On a Western blot with protein from the indicated regions from adult brain, knockdown of MEK1 and MEK2 in mutant mice is shown in comparison to control mice. &#946;-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, Cx: cortex, Amy: amygdala, Hy: hypothalamus, +/flox: shMek<sup>+/flox</sup>, +/&#916;: shMek<sup>+/flox</sup>/Nestin-cre; scale bar in D and E: 1&#8201;mm.</p></caption>
###xml 2743 2743 2721 2721 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm475f6"/>
###xml 895 2743 895 2721 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="70">Analysis of RNA interference in shMek<sup>+/flox</sup>/Nestin-cre mice. (<bold>A</bold>) Tissue specific activation of shRNA in the brain with Nestin-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shMek<sup>+/flox</sup>/Nestin-cre mice. Lane 1: DNA from whole brains of shMek<sup>+/flox</sup> control mice; lane 2&#8211;10: DNA from indicated regions of shMek<sup>+/flox</sup>/Nestin-cre mice. The wild type Rosa26 allele (wt) gives a 5.8&#8201;kb band and the band from the shRNA allele is shifted from 5.4&#8201;kb with the stop cassette (flox) to 8.6&#8201;kb after Cre recombination (del). (<bold>B</bold>) Expression of shRNA against <italic>Mek1</italic> and <italic>Mek2</italic> in whole adult brain. On a Northern blot with small RNAs against the sequence of shMek the 23&#8201;nt band of the processed siRNA against <italic>Mek1</italic> and <italic>Mek2</italic> is highly detectable with the control oligonucleotide and in mutant mice but not in control mice. (<bold>C&#8211;E</bold>) Knockdown of <italic>Mek1</italic> mRNA. On a Northern blot of total RNA from whole adult brain (<bold>C</bold>) <italic>Mek1</italic> mRNA from mutant mice is decreased &#8764;65% compared to control mice. <italic>&#946;-Actin</italic> was used as a loading control. <italic>In situ</italic> hybridization against <italic>Mek1</italic> mRNA on coronal brain sections shows the knockdown effect throughout the brain of mutant mice (E) in contrast to the high wildtype expression of <italic>Mek1</italic> mRNA in control mice (<bold>D</bold>). (<bold>F</bold>) MEK1 and MEK2 protein reduction in the brain of shMek<sup>+/flox</sup>/Nestin-cre mice. On a Western blot with protein from the indicated regions from adult brain, knockdown of MEK1 and MEK2 in mutant mice is shown in comparison to control mice. &#946;-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, Cx: cortex, Amy: amygdala, Hy: hypothalamus, +/flox: shMek<sup>+/flox</sup>, +/&#916;: shMek<sup>+/flox</sup>/Nestin-cre; scale bar in D and E: 1&#8201;mm.</p></caption><graphic xlink:href="gkm475f6"/></fig>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1149 1153 <span type="species:ncbi:10090">mice</span>
###xml 1208 1212 <span type="species:ncbi:10090">mice</span>
###xml 1278 1282 <span type="species:ncbi:10090">mice</span>
###xml 1727 1731 <span type="species:ncbi:10090">mice</span>
###xml 1751 1755 <span type="species:ncbi:10090">mice</span>
###xml 1868 1872 <span type="species:ncbi:10090">mice</span>
###xml 1923 1927 <span type="species:ncbi:10090">mice</span>
###xml 2095 2099 <span type="species:ncbi:10090">mice</span>
###xml 2172 2176 <span type="species:ncbi:10090">mice</span>
###xml 2257 2261 <span type="species:ncbi:10090">mice</span>
###xml 2376 2380 <span type="species:ncbi:10090">mice</span>
###xml 2415 2419 <span type="species:ncbi:10090">mice</span>
In contrast to the CamKII promoter, the Nestin promoter drives the expression of Cre recombinase in all nervous tissue (21). To show the deletion of the stop cassette from the U6-shMek-flox vector in the whole brain of adult mice, a Southern blot was performed in the same way as for the shBraf-flox mice. Also here the band from the shRNA allele is shifted from 5.4 kb with the stop cassette to 8.6 kb after Cre recombination (Figure 6A). The larger band is visible in all brain regions of mutant mice, but not in control mice. The 5.4 kb band from the inactive shRNA allele is absent in all brain regions from mutant mice, indicating complete Cre mediated recombination and therefore shRNA activation in the whole adult brain. Hence, we could show high expression of the shMek transcript in mutant mice but not in control mice on a Northern blot with short RNAs from whole brains (Figure 6B). Figure 6.Analysis of RNA interference in shMek+/flox/Nestin-cre mice. (A) Tissue specific activation of shRNA in the brain with Nestin-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shMek+/flox/Nestin-cre mice. Lane 1: DNA from whole brains of shMek+/flox control mice; lane 2-10: DNA from indicated regions of shMek+/flox/Nestin-cre mice. The wild type Rosa26 allele (wt) gives a 5.8 kb band and the band from the shRNA allele is shifted from 5.4 kb with the stop cassette (flox) to 8.6 kb after Cre recombination (del). (B) Expression of shRNA against Mek1 and Mek2 in whole adult brain. On a Northern blot with small RNAs against the sequence of shMek the 23 nt band of the processed siRNA against Mek1 and Mek2 is highly detectable with the control oligonucleotide and in mutant mice but not in control mice. (C-E) Knockdown of Mek1 mRNA. On a Northern blot of total RNA from whole adult brain (C) Mek1 mRNA from mutant mice is decreased approximately65% compared to control mice. beta-Actin was used as a loading control. In situ hybridization against Mek1 mRNA on coronal brain sections shows the knockdown effect throughout the brain of mutant mice (E) in contrast to the high wildtype expression of Mek1 mRNA in control mice (D). (F) MEK1 and MEK2 protein reduction in the brain of shMek+/flox/Nestin-cre mice. On a Western blot with protein from the indicated regions from adult brain, knockdown of MEK1 and MEK2 in mutant mice is shown in comparison to control mice. beta-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, Cx: cortex, Amy: amygdala, Hy: hypothalamus, +/flox: shMek+/flox, +/Delta: shMek+/flox/Nestin-cre; scale bar in D and E: 1 mm.
###end p 69
###begin p 70
###xml 37 43 37 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 227 233 227 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 289 295 289 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 356 362 356 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 563 564 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 750 754 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 854 857 854 857 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;E</bold>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 939 940 939 940 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 942 946 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1025 1035 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-Actin</italic>
###xml 1067 1074 1052 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1097 1101 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1247 1251 1232 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1274 1275 1259 1260 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1279 1280 1264 1265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1335 1341 1320 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1771 1777 1753 1759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 1793 1799 1771 1777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
###xml 1472 1476 <span type="species:ncbi:10090">mice</span>
###xml 1511 1515 <span type="species:ncbi:10090">mice</span>
Analysis of RNA interference in shMek+/flox/Nestin-cre mice. (A) Tissue specific activation of shRNA in the brain with Nestin-cre. Southern blot analysis of BamHI digested genomic DNA from different brain regions of adult shMek+/flox/Nestin-cre mice. Lane 1: DNA from whole brains of shMek+/flox control mice; lane 2-10: DNA from indicated regions of shMek+/flox/Nestin-cre mice. The wild type Rosa26 allele (wt) gives a 5.8 kb band and the band from the shRNA allele is shifted from 5.4 kb with the stop cassette (flox) to 8.6 kb after Cre recombination (del). (B) Expression of shRNA against Mek1 and Mek2 in whole adult brain. On a Northern blot with small RNAs against the sequence of shMek the 23 nt band of the processed siRNA against Mek1 and Mek2 is highly detectable with the control oligonucleotide and in mutant mice but not in control mice. (C-E) Knockdown of Mek1 mRNA. On a Northern blot of total RNA from whole adult brain (C) Mek1 mRNA from mutant mice is decreased approximately65% compared to control mice. beta-Actin was used as a loading control. In situ hybridization against Mek1 mRNA on coronal brain sections shows the knockdown effect throughout the brain of mutant mice (E) in contrast to the high wildtype expression of Mek1 mRNA in control mice (D). (F) MEK1 and MEK2 protein reduction in the brain of shMek+/flox/Nestin-cre mice. On a Western blot with protein from the indicated regions from adult brain, knockdown of MEK1 and MEK2 in mutant mice is shown in comparison to control mice. beta-ACTIN was used as a loading control. OB: olfactory bulb, HC: hippocampus, St: Striatum, fCx: frontal cortex, pCx: posterior cortex, Th: Thalamus, MB: midbrain, CB: cerebellum, BS: brainstem, Cx: cortex, Amy: amygdala, Hy: hypothalamus, +/flox: shMek+/flox, +/Delta: shMek+/flox/Nestin-cre; scale bar in D and E: 1 mm.
###end p 70
###begin p 71
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 263 271 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 398 405 398 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 509 517 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
Since the shRNA of these mice is specific for both Mek1 and Mek2 mRNA, knockdown should occur at the mRNA and protein level of both genes. But due to the very low expression level of Mek2 mRNA in the adult brain (23), detection of mRNA is possible only for Mek1 (Figure 6C). Quantification of the Northern signal revealed a 65% reduction of mRNA in mutant brains as compared to wild type controls. In situ the reduction of Mek1 mRNA can be observed in the whole brain of mutant mice compared to control mice (Figure 6D and E). On the protein level, reduction of MEK1 and MEK2 protein was observed in the whole brain of mutant mice (Figure 6F). Estimation of levels of protein reduction revealed a knockdown of about approximately65% for MEK1-consistent with the mRNA knockdown-and approximately50% for MEK2 compared to control expression each.
###end p 71
###begin title 72
DISCUSSION
###end title 72
###begin p 73
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 88 94 <span type="species:ncbi:10090">murine</span>
Here, we describe a novel technique to inactivate one or two related genes in the adult murine brain with RNA interference in a tissue-specific manner. We developed conditional shRNA expression vectors that can be activated upon Cre mediated recombination. After testing various configurations for the positional effect of a transcriptional stop cassette within H1 or U6 promoter driven shRNA vectors, we selected one construct with high knockdown efficiency after Cre recombination. Due to the position of the stop cassette, the loop region of the shRNA transcribed from this expression construct is elongated by 34 nt. In contrast to former studies asserting a 9 nt loop sequence being the most efficient configuration (24), our elongated loop sequence does not interfere with shRNA efficiency. Essential for this technique, we could show that the insertion of a loxP flanked stop segment into the loop region of shRNA vectors disrupts RNAi induction and that such vectors can be activated through Cre mediated recombination.
###end p 73
###begin p 74
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 447 452 447 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26 B27 B28">26&#8211;28</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 839 844 <span type="species:ncbi:10090">mouse</span>
An obvious application for conditional RNAi are shRNA vector transgenic mice since a large collection of mouse strains that express Cre recombinase in specific cell types is available and can be used to activate conditional shRNA in different developmental stages and cell types (7). For the genomic integration of such expression vectors, different approaches are available (25). Transgenic RNAi mice have been generated by pronuclear injection (26-28), by lentiviral infection (29) or electroporation of ES cells (3). All these approaches result in random, multicopy integrants of the shRNA vector and therefore require a laborious analysis of multiple lines due to the influence of the genomic environment and the vector copy number on transgene expression (3,27). Apart from the time and resources needed for this initial screening of mouse lines, it is not applicable to conditional shRNA vectors since multicopy integrations could undergo unpredictable and non-functional rearrangements through Cre mediated recombination. Hence, a single-copy approach using a defined and well-characterized genomic locus is preferable.
###end p 74
###begin p 75
###xml 143 148 143 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30 B31 B32">30&#8211;32</xref>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
The HPRT and the Rosa26 locus are frequently used for the genomic integration of expression vectors and have also been used for shRNA vectors (30-32). Since the HPRT locus is affected by X-inactivation in female mice, we chose the Rosa26 locus for integration of our shRNA vectors. Using a reporter gene, we showed in homologous recombinant ES cells that our conditional shRNA expressed from one vector copy in the Rosa26 locus gives rise to highly efficient gene knockdown after Cre mediated recombination, comparable to transient transfections of multiple vector copies. Thus, the Rosa26 locus allows effective and reproducible U6 promoter driven transcription of shRNA and the amount of shRNA transcribed from one single vector integrant is sufficient for efficient gene knockdown. The functionality of the U6 promoter within a defined chromosomal locus, like Rosa26, lays the basis for conditional RNAi in mice using a single vector copy that is recombined by Cre recombinase into a single, predictable product.
###end p 75
###begin p 76
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
To circumvent the laborious and inefficient homologous recombination step for mouse generation, we further used RMCE to produce ES cells harboring one copy of the shRNA expression vector in the Rosa26 locus. With this approach, the frequency of properly recombined ES cell clones among selection positive clones rises from approximately1% with homologous recombination at Rosa26 to 40-60% with RMCE.
###end p 76
###begin p 77
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 421 427 421 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 546 552 546 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 855 859 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 864 868 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 894 898 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 940 946 916 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/flox</sup>
###xml 991 995 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 1000 1004 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek2</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 293 298 <span type="species:ncbi:10090">mouse</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
Our RNAi mice generated with these techniques harbor a conditional shRNA vector either against Braf or Mek1 and Mek2 at once. These mice are viable, fertile, show no overt phenotype, and do not express the specific shRNA before Cre mediated recombination. We used two different Cre expressing mouse lines-both expressing Cre recombinase in a brain-specific manner-to activate shRNA transcription. We showed that in shBraf+/flox/CamKII-cre mice Cre mediated recombination occurs only in neurons of forebrain regions of the adult brain and in shMek+/flox/Nestin-cre mice in all cells of the adult brain, as described previously (20,21). Consequently, shRNA expression and reduction of mRNA and protein is detectable in these tissues from mice expressing Cre recombinase. The extent of specific mRNA and protein knockdown reaches approximately70% in case of Braf and Mek1 and approximately50% for Mek2. Important to mention here is, that shMek+/flox/Nestin-cre mice produce one shRNA targeting Mek1 and Mek2 at once. Although the efficiency of RNAi is not identical for both genes, we show that it is feasible to knockdown several related genes simultaneously.
###end p 77
###begin p 78
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
So, this technique will facilitate functional studies of gene families where the loss of one gene may be compensated by other family members (33,34). Addressing such questions with conventional knockout strategies implies an enormous effort of breeding and genotyping to obtain double or even triple knockout animals. With RNAi, generating multiple knockdown mice is not more effort as compared to single knockdown mice. Furthermore, the production of shRNA expressing mice is much faster and easier than that of knockout mice, especially with the use of RMCE. Thus, in 3-4 months even conditional knockdown mice can be generated whereas at least 12 months are required for the production of a classical unconditional knockout strain. Moreover, the effort of breeding shRNA mice is significantly decreased since only one shRNA allele is required to exert the knockdown of the targeted gene and breeding for homozygosity (as for knockout mice) is not required.
###end p 78
###begin p 79
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRHR1</italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRRK2</italic>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 971 979 971 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1158 1162 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Braf</italic>
###xml 1167 1173 1167 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1/2</italic>
###xml 1919 1924 1907 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1927 1929 1915 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 2173 2177 2161 2165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1</italic>
###xml 2179 2181 2167 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 2550 2552 2538 2540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 1562 1566 <span type="species:ncbi:10090">mice</span>
###xml 1588 1593 <span type="species:ncbi:10090">mouse</span>
###xml 1629 1633 <span type="species:ncbi:10090">mice</span>
###xml 1968 1972 <span type="species:ncbi:10090">mice</span>
###xml 2544 2548 <span type="species:ncbi:10090">mice</span>
In the conditional shRNA mice against MAPKs reported here, we reached knockdown levels of up to 70% after Cre mediated recombination. In the reporter gene experiments, we showed that in ES cells a higher knockdown level of up to 90% is possible with the single-copy approach in the Rosa26 locus. Using shRNAs against the CRHR1 (corticotropin releasing hormone receptor 1) and LRRK2 (leucine-rich repeat kinase 2) genes we indeed obtained knockdown efficiencies of 80 and 90%, respectively, in the adult brain (R. Kuhn, unpublished data). Therefore, the level of knockdown that can be reached in vivo with the Rosa26-shRNA approach is not limited to 70% but rather depends on the intrinsic efficacy of the specific target sequence of an individual shRNA, able to elicit either higher or lower levels of gene silencing. Using public available siRNA prediction programs as paradigm for the design of five shRNA vectors for each gene, we usually find one vector that induces in vitro a knockdown of 90%. This average efficiency should improve in future with the further development of siRNA and shRNA prediction algorithms. To obtain higher knockdown levels for Braf and Mek1/2 the selection of new, more efficient shRNA sequences would be necessary. Another possibility to enhance the efficiency of less potent shRNA sequences may be to increase the number of active siRNAs in the cell. To test whether increased shRNA levels result in improved knockdown, we compared the residual target gene expression in single copy heterozygous and double copy homozygous shRNA mice. In the three tested mouse lines we found in homozygous shRNA mice a moderate (approximately5-10%) but not dramatic increase of knockdown efficiency (C. Hitz, P. Steuber-Buchberger, unpublished data). But even a less potent protein knockdown can result in a phenotype giving interesting insights to the mode of function of the gene. For example Shalin et al. (35) showed impaired fear conditioning in mice with a 40% reduction in ERK1/2 activation. Furthermore, constitutive knockdown with our shRNA against Mek1/2, indeed, does not lead to a placental defect as described for the constitutive knockout of Mek1 (36), but it leads to dwarfism and death at the age of 6 weeks (data not shown). All in all, the doubling of the shRNA copy number and the use of different shRNA target sequences offer the option to exploit differences in efficiency of shRNA sequences to produce allelic series as refined models of genetic diseases beyond the 'all or nothing' principle of knockout mice (37).
###end p 79
###begin p 80
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 985 991 985 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mek1/2</italic>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 562 577 <span type="species:ncbi:10090">transgenic mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
###xml 1259 1264 <span type="species:ncbi:9606">human</span>
We demonstrate that RNAi is a powerful tool for the generation of conditional mouse mutants to study the function of single or related genes in vivo. Recently, Seibler et al. (38) described a new approach for conditional RNAi using the tetO/tetR system. In contrast to our cell type-specific Cre/loxP regulated system the tetR regulated system is reversible and can be switched on and off optionally. However, the tetO/tetR system is not cell type specific and acts simultaneously in all organs and cell types. Since more than 150 strains of tissue specific Cre transgenic mice are available, we expect that our conditional shRNA approach can be applied to a wide range of biological questions in a variety of tissues. Here, we used this approach to generate brain-specific knockdown mice for members of the MAPK pathway to gain insight into the function of this signaling cascade that has been proposed to play a role in mood disorders (10). In a first behavioral characterization of Mek1/2 knockdown mice, we observed a contribution of these kinases to the expression of exploratory and anxiety related behavior (data not shown). Further, more detailed studies using conditional knockdown mice are in progress to establish the relation of this phenotype to human anxiety disorders.
###end p 80
###begin title 81
ACKNOWLEDGEMENTS
###end title 81
###begin p 82
We thank S. Michailidou, S. Kareth, C. Birke, R. Kneuttinger and A. Tasdemir for excellent technical help and G. Hannon for the pSHAG vector. This work has been funded by the Volkswagen Foundation and the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (FKZ:01GR0404). The authors are responsible for the contents of this publication. Funding to pay the Open Access publication charges for this article was provided by the GSF National Research Center.
###end p 82
###begin p 83
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 83
###begin title 84
REFERENCES
###end title 84
###begin article-title 85
Interfering with disease: opportunities and roadblocks to harnessing RNA interference
###end article-title 85
###begin article-title 86
Killing the messenger: short RNAs that silence gene expression
###end article-title 86
###begin article-title 87
Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype
###end article-title 87
###begin article-title 88
Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro
###end article-title 88
###begin article-title 89
Control of siRNA expression using the Cre-loxP recombination system
###end article-title 89
###begin article-title 90
CRE recombinase-inducible RNA interference mediated by lentiviral vectors
###end article-title 90
###begin article-title 91
Creation and use of a Cre recombinase transgenic database
###end article-title 91
###begin article-title 92
The ERK cascade: a prototype of MAPK signaling
###end article-title 92
###begin article-title 93
A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation
###end article-title 93
###begin article-title 94
Finding the intracellular signaling pathways affected by mood disorder treatments
###end article-title 94
###begin article-title 95
Using an in vivo phagemid system to identify non-compatible loxP sequences
###end article-title 95
###begin article-title 96
Cloning of short hairpin RNAs for gene knockdown in mammalian cells
###end article-title 96
###begin article-title 97
A simple assay to determine the functionality of Cre or FLP recombination targets in genomic manipulation constructs
###end article-title 97
###begin article-title 98
Transcriptional activation by tetracyclines in mammalian cells
###end article-title 98
###begin article-title 99
Generalized lacZ expression with the ROSA26 Cre reporter strain
###end article-title 99
###begin article-title 100
###xml 46 61 <span type="species:ncbi:10090">transgenic mice</span>
A generic intron increases gene expression in transgenic mice
###end article-title 100
###begin article-title 101
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Efficient FLP recombination in mouse ES cells and oocytes
###end article-title 101
###begin article-title 102
###xml 65 70 <span type="species:ncbi:9606">human</span>
A phage integrase directs efficient site-specific integration in human cells
###end article-title 102
###begin article-title 103
Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells
###end article-title 103
###begin article-title 104
Essential role for TrkB receptors in hippocampus-mediated learning
###end article-title 104
###begin article-title 105
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
###end article-title 105
###begin article-title 106
Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry
###end article-title 106
###begin article-title 107
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain
###end article-title 107
###begin article-title 108
A system for stable expression of short interfering RNAs in mammalian cells
###end article-title 108
###begin article-title 109
###xml 14 29 <span type="species:ncbi:10090">transgenic mice</span>
Production of transgenic mice
###end article-title 109
###begin article-title 110
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Germline transmission of RNAi in mice
###end article-title 110
###begin article-title 111
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference
###end article-title 111
###begin article-title 112
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
###xml 64 68 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Small interfering RNA and gene silencing in transgenic mice and rats
###end article-title 112
###begin article-title 113
Cre-lox-regulated conditional RNA interference from transgenes
###end article-title 113
###begin article-title 114
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages
###end article-title 114
###begin article-title 115
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Single copy shRNA configuration for ubiquitous gene knockdown in mice
###end article-title 115
###begin article-title 116
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Reproducible and inducible knockdown of gene expression in mice
###end article-title 116
###begin article-title 117
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission
###end article-title 117
###begin article-title 118
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy
###end article-title 118
###begin article-title 119
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Neuronal MEK is important for normal fear conditioning in mice
###end article-title 119
###begin article-title 120
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta
###end article-title 120
###begin article-title 121
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo
###end article-title 121
###begin article-title 122
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Reversible gene knockdown in mice using a tight, inducible shRNA expression system
###end article-title 122

